Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$578M |
| 2 |
Micron Technology
MU
|
+$433M |
| 3 |
Advanced Micro Devices
AMD
|
+$404M |
| 4 |
Amazon
AMZN
|
+$398M |
| 5 |
Accenture
ACN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$777M |
| 2 |
Meta Platforms (Facebook)
META
|
+$752M |
| 3 |
Tesla
TSLA
|
+$627M |
| 4 |
Chevron
CVX
|
+$528M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.46% |
| 2 | Technology | 18.58% |
| 3 | Consumer Staples | 10.15% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Financials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Nurix Therapeutics
NRIX
$2.81B
| $955K | ﹤0.01% |
73,300
-45,100
| -38% | -$714K |
|
2527
Akebia Therapeutics
AKBA
$242M
| $954K | ﹤0.01% |
3,016,427
+1,534,127
| +103% | +$602K |
|
2528
nLIGHT
LASR
$3.03B
| $954K | ﹤0.01% |
101,000
-28,600
| -22% | -$330K |
|
2529
Cue Biopharma
CUE
$144M
| $950K | ﹤0.01% |
14,205
-5,118
| -26% | -$440K |
|
2530
Sonida Senior Living
SNDA
$1.88B
| $950K | ﹤0.01% |
58,491
-9,900
| -14% | -$194K |
|
2531
Boston Omaha
BOC
$421M
| $949K | ﹤0.01% |
41,200
-29,900
| -42% | -$741K |
|
2532
Larimar Therapeutics
LRMR
$453M
| $948K | ﹤0.01% |
296,367
+120,825
| +69% | +$303K |
|
2533
Prelude Therapeutics
PRLD
$443M
| $948K | ﹤0.01% |
143,400
-17,086
| -11% | -$115K |
|
|
CFB
2534
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $945K | ﹤0.01% |
72,400
+500
| +0.7% | +$6.78K |
|
|
AFBI
2535
DELISTED
Affinity Bancshares
AFBI
| $942K | ﹤0.01% |
64,504
-7,900
| -11% | -$117K |
|
2536
Cars.com
CARS
$663M
| $942K | ﹤0.01% |
81,900
+37,000
| +82% | +$437K |
|
2537
Westamerica Bancorp
WABC
$1.38B
| $941K | ﹤0.01% |
18,000
-2,100
| -10% | -$120K |
|
2538
Minerva Neurosciences
NERV
$219M
| $940K | ﹤0.01% |
101,800
+66,189
| +186% | +$392K |
|
2539
Vanguard Ultra-Short Bond ETF
VUSB
$9.34B
| $940K | ﹤0.01% |
19,200
-5,900
| -24% | -$290K |
|
2540
Codexis
CDXS
$171M
| $939K | ﹤0.01% |
+154,992
| New | +$1.25M |
|
2541
Jones Lang LaSalle
JLL
$17.3B
| $937K | ﹤0.01% |
6,200
-11,600
| -65% | -$2.02M |
|
2542
IHS Holding
IHS
$2.82B
| $936K | ﹤0.01% |
167,800
+76,400
| +84% | +$585K |
|
2543
Scholastic
SCHL
$781M
| $935K | ﹤0.01% |
30,401
+2,801
| +10% | +$117K |
|
2544
Ingredion
INGR
$6.63B
| $934K | ﹤0.01% |
11,600
-47,500
| -80% | -$4.17M |
|
|
PINE
2545
Alpine Income Property Trust
PINE
$348M
| $926K | ﹤0.01% |
57,078
-55,953
| -50% | -$1.01M |
|
|
PFHD
2546
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $926K | ﹤0.01% |
35,700
+21,000
| +143% | +$535K |
|
|
DALN
2547
DELISTED
DallasNews
DALN
| $924K | ﹤0.01% |
199,051
-21,100
| -10% | -$135K |
|
2548
Neurogene
NGNE
$723M
| $923K | ﹤0.01% |
72,103
-8,610
| -11% | -$176K |
|
2549
Citizens
CIA
$201M
| $920K | ﹤0.01% |
275,594
-25,700
| -9% | -$97.6K |
|
2550
Ranpak Holdings
PACK
$478M
| $920K | ﹤0.01% |
269,113
+181,313
| +207% | +$996K |
|
Similar funds
Jim Simons's Q3 2022 Portfolio in Review
As of Q3 2022, Jim Simons held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $8.71B in Q3 2022, closing 637 positions and reducing 2,164 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Alphabet (Google) Class A worth $498M.
- Jim Simons's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
- Jim Simons added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
- Jim Simons's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
- Jim Simons fully exited Shopify in Q3 2022, selling an estimated $439M.
- Jim Simons's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
- Jim Simons opened 441 new positions and closed 637 in Q3 2022.
- Jim Simons's portfolio value fell 16% quarter-over-quarter to $70.7B.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.